Best Pharmaceutical Dividend Stocks - For Big Profits in 2024
The pharmaceutical industry is one of the most stable and essential sectors in the global economy, offering a blend of innovation, growth, and reliability for investors. With an aging population and increasing demand for healthcare solutions, pharmaceutical companies continue to develop life-saving drugs and treatments, driving consistent revenue streams. For dividend investors, this industry provides an attractive opportunity, as many large pharmaceutical firms offer substantial dividend payouts backed by strong cash flows and a commitment to shareholder returns. We’ll highlight the best pharmaceutical dividend stocks that can provide both income and growth potential. Investing in this sector can help diversify your portfolio with companies at the forefront of medical advancements while benefiting from stable, long-term dividends.
| Stock | Dividend Yield | Pay-out Ratio | P/E Ratio | P/B Ratio | ROE | 5y Dividend Growth | 10y Dividend Growth |
|---|---|---|---|---|---|---|---|
| Aarti Drugs | 0.20% | 0.00% | 29.02% | 3.55% | 0.13% | 0.00% | -18.77% |
| AbbVie | 4.11% | 201.82% | 62.54% | 49.26% | 0.57% | 10.52% | 13.98% |
| Alembic Pharmaceuticals | 0.96% | 0.00% | 35.59% | 4.65% | 0.14% | 14.87% | 12.33% |
| Almirall | 1.62% | -12.62% | -73.91% | 1.30% | -0.02% | 0.00% | 7.67% |
| Amgen | 2.78% | 150.06% | 54.84% | 28.97% | 0.50% | 10.04% | 16.31% |
| Aspen Pharmacare | 1.98% | 28.24% | 9.93% | 0.95% | 0.09% | 0.00% | 0.00% |
| AstraZeneca | 1.91% | 69.29% | 37.22% | 6.07% | 0.17% | 0.42% | -6.50% |
| Bayer | 0.33% | -9.48% | -5.05% | 0.18% | -0.04% | -10.74% | -14.18% |
| Bio-Techne | 0.45% | 29.99% | 66.08% | 5.37% | 0.08% | -24.21% | -12.45% |
| Biocon | 0.15% | 0.00% | 24.74% | 1.55% | 0.08% | 0.00% | 0.00% |
| Bliss GVS Pharma | 0.38% | 0.00% | 16.96% | 1.38% | 0.08% | -12.94% | -3.31% |
| Bristol-Myers Squibb | 4.60% | -73.08% | -16.15% | 6.21% | -0.28% | 7.34% | 2.62% |
| Chugai Pharmaceutical | 0.53% | 36.97% | 16.22% | 3.29% | 0.22% | 0.00% | 0.00% |
| Cipla | 0.86% | 0.00% | 28.34% | 4.55% | 0.17% | 23.16% | 15.57% |
| Carlisle Companies | 0.76% | 9.40% | 12.63% | 7.37% | 0.60% | 15.75% | 14.31% |
| CVS Health | 5.85% | 45.29% | 9.93% | 0.95% | 0.10% | 3.89% | 10.40% |
| Eisai | 3.05% | 140.67% | 46.90% | 1.71% | 0.04% | -3.76% | -38.62% |
| Eli Lilly | 0.55% | 59.60% | 111.55% | 60.39% | 0.61% | 14.97% | 8.71% |
| Faes Farma | 4.29% | 10.25% | 9.49% | 1.64% | 0.18% | 6.21% | -0.03% |
| Fagron | 1.12% | 26.69% | 17.69% | 2.91% | 0.17% | 28.99% | 0.00% |
| Hikal | 0.32% | 0.00% | 67.53% | 3.85% | 0.06% | 0.00% | -7.08% |
| Hualan Biological Engineering | 1.85% | 72.85% | 21.16% | 2.62% | 0.12% | 0.00% | 11.61% |
| Ipsen | 1.21% | 22.75% | 10.99% | 2.38% | 0.23% | 3.39% | -0.07% |
| Jubilant Pharmova | 0.42% | 0.00% | 33.83% | 3.45% | 0.10% | 10.76% | 5.24% |
| Kobayashi Pharmaceutical | 1.75% | 0.00% | 30.79% | 2.01% | 0.07% | 8.88% | 1.62% |
| Kyowa Kirin | 2.12% | 30.94% | 14.39% | 1.62% | 0.12% | 6.82% | 12.16% |
| Neuland Laboratories | 0.10% | 0.00% | 52.00% | 13.62% | 0.28% | 0.00% | 0.00% |
| Nippon Shinyaku | -% | 30.35% | 2.35% | 0.28% | 0.13% | 5.34% | 0.00% |
| Novartis | 6.61% | 47.13% | 14.37% | 5.57% | 0.39% | 5.40% | 4.35% |
| Novo Nordisk | 1.25% | 46.71% | 39.90% | 31.88% | 0.87% | 10.60% | -5.84% |
| Perrigo | 4.26% | -126.82% | -29.57% | 0.78% | -0.03% | 7.52% | 11.43% |
| Pfizer | 5.79% | -360.95% | -62.87% | 1.86% | -0.03% | 4.08% | 5.50% |
| Pharma Mar | 0.93% | -648.50% | -699.19% | 6.79% | -0.01% | 0.00% | 0.00% |
| Rohto Pharmaceutical | 0.89% | 0.00% | 26.19% | 3.03% | 0.12% | 34.27% | 18.22% |
| Royalty Pharma | 2.99% | 54.64% | 18.59% | 1.93% | 0.11% | 0.00% | 0.00% |
| Sanofi | 3.00% | 59.74% | 15.65% | 1.70% | 0.11% | 12.94% | -11.90% |
| Sanofi India | 2.49% | 0.00% | 29.13% | 22.52% | 0.62% | 20.85% | 16.72% |
| SIGA Technologies | 8.72% | 127.36% | 5.83% | 2.92% | 0.51% | 0.00% | 0.00% |
| Sino Biopharmaceutical | 2.45% | 17.11% | 16.92% | 0.28% | 0.02% | -1.82% | 21.15% |
| Viatris | 4.15% | -89.13% | -21.32% | 0.71% | -0.03% | 0.00% | 0.00% |
| Virbac | 0.38% | 7.84% | 20.62% | 2.92% | 0.15% | 0.00% | 0.00% |
| Zoetis | 0.88% | 31.57% | 36.83% | 17.38% | 0.47% | 24.37% | 22.63% |
| Zydus Lifesciences | 0.30% | 0.00% | 23.72% | 5.01% | 0.21% | 11.38% | -2.21% |
| Cardinal Health | 1.79% | 58.57% | 32.14% | -8.52% | -0.25% | 1.10% | 5.38% |
| Gilead Sciences | 4.34% | 366.38% | 104.40% | 6.01% | 0.05% | 5.64% | 0.00% |
| Walgreens Boots Alliance | 11.77% | -14.59% | -1.05% | 0.86% | -0.53% | 2.71% | 4.99% |
| GSK | 3.06% | 58.39% | 29.62% | 8.31% | 0.29% | -4.37% | -3.27% |
| Abbott Laboratories | 2.37% | 48.66% | 35.20% | 0.00% | 0.20% | 12.74% | 13.80% |
| Danaher | 0.40% | 14.83% | 48.54% | 3.68% | 0.07% | 10.41% | 26.51% |
| Johnson & Johnson | 3.73% | 59.38% | 27.03% | 5.55% | 0.21% | 5.83% | 6.14% |
| Thermo Fisher Scientific | 0.33% | 8.92% | 36.01% | 4.72% | 0.13% | 15.54% | 8.84% |